Sinomenine inhibits microglial activation by Aβ and confers neuroprotection

Abstract

BackgroundNeuroinflammation is an important contributor to the development of neurodegenerative diseases, including Alzheimer's disease. Thus, there is a keen interest in identifying compounds, especially from herbal sources, that can inhibit neuroinflammation. Amyloid-β (Aβ) is a major component of the amyloid plaques present in the brains of Alzheimer's disease patients. Here, we examined whether sinomenine, present in a Chinese medicinal plant, prevents oligomeric Aβ-induced microglial activation and confers protection against neurotoxicity.MethodsOligomeric amyloid-β was prepared from Aβ(1-42). Intracellular reactive oxygen species production was determined using the dye 2',7'-dichlorodihydrofluorescin diacetate. Nitric oxide level was assessed using the Griess reagent. Flow cytometry was used to examine the levels of inflammatory molecules. BV2-conditioned medium was used to treat hippocampal cell line (HT22) and primary hippocampal cells in indirect toxicity experiments. Toxicity was assessed using MTT reduction and TUNEL assays.ResultsWe found that sinomenine prevents the oligomeric Aβ-induced increase in levels of reactive oxygen species and nitric oxide in BV2 microglial cells. In addition, sinomenine reduces levels of Aβ-induced inflammatory molecules. Furthermore, sinomenine protects hippocampal HT22 cells as well as primary hippocampal cells from indirect toxicity mediated by Aβ-treated microglial cells, but has no effect on Aβ-induced direct toxicity to HT22 cells. Finally, we found that conditioned medium from Aβ-treated BV2 cells contains increased levels of nitric oxide and inflammatory molecules, but the levels of these molecules are reduced by sinomenine.ConclusionsSinomenine prevents oligomeric Aβ-induced microglial activation, and confers protection against indirect neurotoxicity to hippocampal cells. These results raise the possibility that sinomenine may have therapeutic potential for the treatment of Alzheimer's diseases as well as other diseases that involve neuroinflammation.

HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

“…Another suggested approach is to regulate the transporters responsible for modulation of extracellular glutamate, such as the cystine–glutamate transporter, which is profoundly upregulated in microglia that are activated by tat 150 . Unfortunately, no clinically available brain-penetrating inhibitors exist to test this hypothesis in patients, but preclinical development is underway 151,152 .…”

Modulators of microglial activation and polarization after intracerebral haemorrhage

“…As discussed above, rapamycin (at a low dose of 150 μg/kg) increased levels of M2-like anti-inflammatory cytokines IL-10 and TGFβ 105 . Sinomenine is a dextrorotatory morphinan analogue extracted from herbs used in traditional Chinese medicine 195,196 , and has long been used clinically for treating rheumatoid arthritis in China 197 . In vitro , sinomenine reduced levels of pro-inflammatory cytokines IL-1β, IL-6 and TNF in ICH-exposed BV-2 microglia 198 and increased levels of M2-like markers IL-10 and Arg1 in primary microglia exposed to erythrocyte lysate 199 .…”

Cudrania cochinchinensis attenuates amyloid β protein-mediated microglial activation and promotes glia-related clearance of amyloid β protein

“…It has been indicated previously that oAβ possesses the ability to stimulate nitric oxide production from the activated BV-2 cells [22] or primary microglia [23]. Furthermore, it has been suggested that oAβ and fAβ stimulate differential activation on primary microglia [24], since oAβ is a stronger M1-inductor than fAβ [25].…”